Results 61 to 70 of about 8,858,582 (250)

Salmonella lipopolysaccharide‐containing supported lipid bilayers as platforms to study bacteriophage interactions

open access: yesFEBS Letters, EarlyView.
We present robust protocols for the preparation of supported lipid bilayers (SLBs) incorporating either Salmonella smooth LPS or outer membrane vesicles (OMVs). We use a combination of quartz crystal microbalance with dissipation (QCM‐D) and fluorescence microscopy to both characterize the SLBs of various compositions and to probe their interactions ...
Hudson P. Pace   +6 more
wiley   +1 more source

A Gene Family-led Meta-Analysis of Drug-Target Interactions

open access: yes, 2018
The shift from "magic bullets" to "magic shotguns" has prospered the pharmaceutical industry, where a belief is that a drug that"hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may
Stephan Schurer   +5 more
core   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces

open access: yesBMC Bioinformatics, 2019
Background Detection of new drug-target interactions by computational algorithms is of crucial value to both old drug repositioning and new drug discovery.
Yi Zheng   +5 more
doaj   +1 more source

Numbers of drugs, proteins, and drug-target interactions used in this research.

open access: yes, 2013
(a) Drug-target interactions from ChEMBL are combined with side effects and from SIDER and drufgs.com databases. (b) Drug-target interactions from STITCH are combined with side effects and from SIDER and STITCH databases.
Shinhyuk Kim (488151)   +2 more
core   +1 more source

Additional file 1 of Using BERT to identify drug-target interactions from whole PubMed

open access: yes, 2022
Additional file 1.
Markus Vähä-Koskela (275879)   +3 more
core   +1 more source

Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients [PDF]

open access: yes, 2022
Drug interactions with other drugs are a well-known phenomenon. Similarly, however, pre-existing drug therapy can alter the course of diseases for which it has not been prescribed.
Verena Schöning   +3 more
core   +2 more sources

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Using BERT to identify drug-target interactions from whole PubMed

open access: yesBMC Bioinformatics, 2022
Background Drug-target interactions (DTIs) are critical for drug repurposing and elucidation of drug mechanisms, and are manually curated by large databases, such as ChEMBL, BindingDB, DrugBank and DrugTargetCommons.
Jehad Aldahdooh   +3 more
doaj   +1 more source

The number of drug compounds and target proteins, their ratio, and the number of interactions in the drug-target datasets from[12].

open access: yes, 2013
The number of drug compounds and target proteins, their ratio, and the number of interactions in the drug-target datasets from[12].
Elena Marchiori (427195)   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy